Print

BioTrends Announces Newly Expanded Oncology Division to Focus on Launch Metrics of Bristol-Myers Squibb Company (BMY)'s Yervoy, Roche (RHHBY) and Daiichi Sankyo, Inc. (D4S.F)'s Zelboraf, Pfizer Inc. (PFE)'s Xalkori and Johnson & Johnson (JNJ)'s Zytiga  
9/15/2011 9:46:36 AM

EXTON, Pa.--(BUSINESS WIRE)--The Oncology marketplace is going through a paradigm shift with new product launches and competitive promotion vying for patient treatment share. These new marketing reports written by Oncology experts will provide essential insights into the market dynamics.
//-->